東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Vaccines, medicines and COVID-19 = h...

Velasquez, German.

Linked to FindBook

Google Book

Amazon

博客來

Vaccines, medicines and COVID-19 = how can WHO be given a stronger voice? /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Vaccines, medicines and COVID-19/ by German Velasquez.
Reminder of title:	how can WHO be given a stronger voice? /
Author:	Velasquez, German.
Published:	Cham :Springer International Publishing : : 2022.,
Description:	xvi, 117 p. :ill., digital ;24 cm.
[NT 15003449]:	Chapter 1: COVID-19 Vaccines: Between Ethics, Health and Economics -- Chapter 2: Medicines and Intellectual Property: 10 Years of the WHO Global Strategy -- Chapter 3: Re-thinking Global and Local Manufacturing of Medical Products After COVID-19 -- Chapter 4: Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock -- Chapter 5: Intellectual Property and Access to Medicines and Vaccines -- Chapter 6: The World Health Organization Reforms in the Time of COVID-19 -- Epilogue.
Contained By:	Springer Nature eBook
Subject:	COVID-19 Pandemic, 2020- -
Online resource:	https://doi.org/10.1007/978-3-030-89125-1
ISBN:	9783030891251

Vaccines, medicines and COVID-19 = how can WHO be given a stronger voice? /
Velasquez, German.

Vaccines, medicines and COVID-19how can WHO be given a stronger voice? /[electronic resource] :by German Velasquez. - Cham :Springer International Publishing :2022. - xvi, 117 p. :ill., digital ;24 cm. - SpringerBriefs in public health,2192-3701. - SpringerBriefs in public health..

Chapter 1: COVID-19 Vaccines: Between Ethics, Health and Economics -- Chapter 2: Medicines and Intellectual Property: 10 Years of the WHO Global Strategy -- Chapter 3: Re-thinking Global and Local Manufacturing of Medical Products After COVID-19 -- Chapter 4: Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock -- Chapter 5: Intellectual Property and Access to Medicines and Vaccines -- Chapter 6: The World Health Organization Reforms in the Time of COVID-19 -- Epilogue.

Open access.

This open access book is a collection of research papers on COVID-19 by German Velasquez from 2020 and early 2021 that help to answer the question: How can an agency like the World Health Organization (WHO) be given a stronger voice to exercise authority and leadership? The considerable health, economic and social challenges that the world faced at the beginning of 2020 with COVID-19 continued and worsened in many parts of the world in the second-half of 2020 and into 2021. Many of these countries and nations wanted to explore COVID-19 on their own, sometimes without listening to the main international health bodies such as WHO, an agency of the United Nations system with long-standing experience and vast knowledge at the global level and of which all countries in the world are members. In this single volume, the chapters present the progress of thinking and debate - particularly in relation to drugs and vaccines - that would enable a response to the COVID-19 pandemic or to subsequent crises that may arise. Among the topics covered: COVID-19 Vaccines: Between Ethics, Health and Economics Medicines and Intellectual Property: 10 Years of the WHO Global Strategy Re-thinking Global and Local Manufacturing of Medical Products After COVID-19 Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock Intellectual Property and Access to Medicines and Vaccines The World Health Organization Reforms in the Time of COVID-19 Vaccines, Medicines and COVID-19: How Can WHO Be Given a Stronger Voice? is essential reading for negotiators from the 194 member countries of the World Health Organization (WHO); World Trade Organization (WTO) and World Intellectual Property Organization (WIPO) staff participating in these negotiations; academics and students of public health, medicine, health sciences, law, sociology and political science; and intergovernmental organizations and non-governmental organizations that follow the issue of access to treatments and vaccines for COVID-19.

ISBN: 9783030891251

Standard No.: 10.1007/978-3-030-89125-1doiSubjects--Corporate Names:

623347
World Health Organization.
Subjects--Topical Terms:

3489935
COVID-19 Pandemic, 2020-

LC Class. No.: RA644.C67 / V45 2022

Dewey Class. No.: 362.1962414

Vaccines, medicines and COVID-19 = how can WHO be given a stronger voice? /
LDR:03613nmm a2200349 a 4500 001 2297604
003 DE-He213
005 20211224170454.0
006 m d
007 cr nn 008maaau
008 230324s2022 sz s 0 eng d
020 $a 9783030891251 $q (electronic bk.)
020 $a 9783030891244 $q (paper)
024 7 $a 10.1007/978-3-030-89125-1 $2 doi
035 $a 978-3-030-89125-1
040 $a GP $c GP
041 1 $a eng $h fre
050 4 $a RA644.C67 $b V45 2022
072 7 $a MBN $2 bicssc
072 7 $a MED076000 $2 bisacsh
072 7 $a MBN $2 thema
082 0 4 $a 362.1962414 $2 23
090 $a RA644.C67 $b V434 2022
100 1 $a Velasquez, German. $3 3593418
245 1 0 $a Vaccines, medicines and COVID-19 $h [electronic resource] : $b how can WHO be given a stronger voice? / $c by German Velasquez.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a xvi, 117 p. : $b ill., digital ; $c 24 cm.
490 1 $a SpringerBriefs in public health, $x 2192-3701
505 0 $a Chapter 1: COVID-19 Vaccines: Between Ethics, Health and Economics -- Chapter 2: Medicines and Intellectual Property: 10 Years of the WHO Global Strategy -- Chapter 3: Re-thinking Global and Local Manufacturing of Medical Products After COVID-19 -- Chapter 4: Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock -- Chapter 5: Intellectual Property and Access to Medicines and Vaccines -- Chapter 6: The World Health Organization Reforms in the Time of COVID-19 -- Epilogue.
506 $a Open access.
520 $a This open access book is a collection of research papers on COVID-19 by German Velasquez from 2020 and early 2021 that help to answer the question: How can an agency like the World Health Organization (WHO) be given a stronger voice to exercise authority and leadership? The considerable health, economic and social challenges that the world faced at the beginning of 2020 with COVID-19 continued and worsened in many parts of the world in the second-half of 2020 and into 2021. Many of these countries and nations wanted to explore COVID-19 on their own, sometimes without listening to the main international health bodies such as WHO, an agency of the United Nations system with long-standing experience and vast knowledge at the global level and of which all countries in the world are members. In this single volume, the chapters present the progress of thinking and debate - particularly in relation to drugs and vaccines - that would enable a response to the COVID-19 pandemic or to subsequent crises that may arise. Among the topics covered: COVID-19 Vaccines: Between Ethics, Health and Economics Medicines and Intellectual Property: 10 Years of the WHO Global Strategy Re-thinking Global and Local Manufacturing of Medical Products After COVID-19 Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock Intellectual Property and Access to Medicines and Vaccines The World Health Organization Reforms in the Time of COVID-19 Vaccines, Medicines and COVID-19: How Can WHO Be Given a Stronger Voice? is essential reading for negotiators from the 194 member countries of the World Health Organization (WHO); World Trade Organization (WTO) and World Intellectual Property Organization (WIPO) staff participating in these negotiations; academics and students of public health, medicine, health sciences, law, sociology and political science; and intergovernmental organizations and non-governmental organizations that follow the issue of access to treatments and vaccines for COVID-19.
610 2 0 $a World Health Organization. $3 623347
650 0 $a COVID-19 Pandemic, 2020- $3 3489935
650 0 $a Vaccines. $3 684854
650 0 $a COVID-19 (Disease) $3 3473310
650 0 $a COVID-19 (Disease) $x Political aspects. $3 3480264
650 0 $a COVID-19 (Disease) $x Social aspects. $3 3480263
650 1 4 $a Health Promotion and Disease Prevention. $3 894308
650 2 4 $a Health Policy. $3 630834
650 2 4 $a Chemistry/Food Science, general. $3 894122
650 2 4 $a Biotechnology. $3 571461
650 2 4 $a Biomaterials. $3 898413
650 2 4 $a Public Health. $3 624351
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a SpringerBriefs in public health. $3 1567201
856 4 0 $u https://doi.org/10.1007/978-3-030-89125-1
950 $a Medicine (SpringerNature-11650)